02.09.10
FlowCardia, Inc.
Initiates CENTRAL Study Enrollment
01.08.10
Mark Page appointed Vice President
Marketing for FlowCardia, Inc
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|||||||||||||||||
|
|||||||||||||||||
|
|||||||||||||||||
|
FlowCardia, Inc. is uniquely positioned to provide exceptional, endovascular tools for crossing chronic total occlusions (CTOs) in the leg and coronary arteries. The CROSSER® CTO Recanalization Catheter, Steerable Supporting Catheters and the Porter Guidewires comprise a family of minimally invasive devices which enable physicians to quickly cross CTOs allowing for subsequent and more definitive therapies such as atherectomy, balloon angioplasty, and stent implantation. | |
|||||||||||||||
|
02.09.10 |
01.08.10 |
|
||||||||||||||
|
|||||||||||||||||
|
|
||||||||||||||||
|